2. Gastritis
📄 Definition
Gastritis refers to inflammation of the gastric mucosa, which may be acute or chronic. It can be caused by infection, irritants, autoimmune disease, or other systemic conditions.
🛡️ Aetiology / Risk Factors (Mnemonic: HANGING)
Helicobacter pylori infection
Autoimmune gastritis (anti-parietal cell / intrinsic factor antibodies)
NSAIDs or aspirin
Glucocorticoids (especially with NSAIDs)
Irritants: alcohol, caffeine, spicy food
Nicotine (smoking)
Gastro-oesophageal reflux (associated)
📋 Clinical Features (Mnemonic: PAINED)
Post-prandial epigastric pain
Anaemia (from chronic GI blood loss in erosive gastritis)
Indigestion / dyspepsia
Nausea and/or vomiting
Early satiety or bloating
Dark stools (melaena) in haemorrhagic cases
Note: Symptoms often overlap with peptic ulcer disease and functional dyspepsia.
⚠️ Alarm Features (Mnemonic: ALARM55)
Refer for urgent OGD if the patient presents with:
Anaemia (iron deficiency)
Loss of weight
Anorexia
Recent-onset dysphagia
Melaena or haematemesis
Age ≥55 with new-onset symptoms
1.
Initial Clinical Assessment
Exclude red flags: dysphagia, weight loss, anaemia, vomiting, GI bleeding, mass, or family history of GI cancer.
Assess for NSAID use, alcohol, smoking, or stress.
Consider overlap with GORD, PUD, or functional dyspepsia.
2.
H. pylori Testing — When to Test?
Test for H. pylori if:
Uninvestigated dyspepsia (especially <55 years and no red flags)
Symptoms persist after PPI trial
Previous history of gastric/duodenal ulcer or gastritis
Planned long-term NSAID use, especially in patients >45 years
Known iron-deficiency anaemia, or ITP/B12 deficiency
Do NOT routinely test:
If asymptomatic and no history of ulcers or risk factors
During/after recent PPI use unless stopped for 2 weeks
In patients with alarming features — refer for OGD instead
3.
H. pylori Testing — Which Test to Use?
| Test | When to Use | Notes |
|---|---|---|
| Urea Breath Test (UBT) | 1st-line | Stop PPI ≥2 weeks prior |
| Stool Antigen Test | 1st-line | Preferred in primary care |
| Serology (Blood Test) | Avoid | Not reliable for active infection |
| OGD + Biopsy | If red flags or treatment failure | Also rules out malignancy, ulcers |
Follow-Up Testing
Confirm eradication 4 weeks after completing triple therapy (if given) using urea breath test or stool antigen — not serology.
Summary for PARA:
Test H. pylori in persistent dyspepsia without alarm features. Use stool antigen or breath test (PPIs stopped 2 weeks prior). Do not test if alarm symptoms present — refer for endoscopy.
💊 Treatment –
1️⃣ Lifestyle First
Stop NSAIDs (if safe), reduce alcohol/caffeine, stop smoking
Antacids or alginates for symptom relief
2️⃣ Empirical PPI Trial
Omeprazole 20 mg OD for 4 weeks
First-line for uncomplicated dyspepsia
If symptoms resolve → step down/stop
3️⃣ Test for H. pylori
Only if symptoms persist after PPI
Stop PPI for 2 weeks prior to testing
Use stool antigen or urea breath test
PHE: test after PPI trial due to low UK prevalence (<15%)
4️⃣ Treat if H. pylori Positive
Triple therapy: PPI + amoxicillin + clarithromycin/metronidazole (7 days)
Confirm eradication after 4 weeks
5️⃣ Ongoing Symptoms
Consider prolonged PPI or add H2RA
Refer for OGD if red flags or non-response
Manage autoimmune causes (e.g. B12 if needed)
Co-prescribe PPI with long-term NSAID use
⚠️Complications (Mnemonic: BAGS)
Bleeding – from erosive gastritis
Anaemia – iron or B12 deficiency
Gastric atrophy – in chronic autoimmune gastritis
Stomach cancer – associated with H. pylori and chronic inflammation
🔎 Autoimmune Gastritis
More common in older women
Associated with pernicious anaemia, thyroid disease, T1DM
Investigations: B12 level, anti-parietal cell and anti-intrinsic factor antibodies
Management: lifelong B12 injections if deficient
Last updated in line with NICE CKS: Dyspepsia – acute and chronic
Published: May 2010 • Last updated: April 2023
Last reviewed: July 2025
PASSMAP ensures all content is NICE-aligned and reviewed for Physician Associate Registration Assessment (PARA) success.
